You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EYS mutation

Showing 1 - 25 of 2,564
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rate of Progression in EYS Related Retinal Degeneration

Active, not recruiting
  • Retinitis Pigmentosa
  • Eye Diseases
    • San Francisco, California
    • +19 more
    Feb 3, 2022

    The Prevelence of HBB c.93-21 G-A in ß Thalassemia Patients

    Recruiting
    • Beta-Thalassemia
    • ARMS PCR
    • Assiut, Egypt
      Faculty of Medicine Assiut University
    Jan 30, 2023

    Predictive Cancer Model Trial in Prague (colonoscopy)

    Recruiting
    • Predictive Cancer Model
    • colonoscopy
    • Prague, Czechia
      Military University Hospital
    Jun 25, 2023

    Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)

    Recruiting
    • Advanced or Metastatic Solid Tumor
    • KRAS G12C Mutation
    • Changsha, Hunan, China
      Xiangya Hospital of Central South University
    Nov 2, 2023

    GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

    Not yet recruiting
    • GATA2 Gene Mutation
    • Biological samples (blood and bone marrow samples).
    • Angers, France
    • +16 more
    Jul 31, 2023

    Advanced Solid Tumor Trial in Guangzhou (YL-17231)

    Recruiting
    • Advanced Solid Tumor
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 5, 2023

    Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Vienna, Austria
    • +3 more
    Jun 8, 2023

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    Cystic Fibrosis Trial in Worldwide (VX-121/TEZ/D-IVA, ELX/TEZ/IVA, IVA)

    Active, not recruiting
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +169 more
    Dec 22, 2022

    DDX41 Gene Mutation Trial in France (For each person (index case or related) included in this study:)

    Not yet recruiting
    • DDX41 Gene Mutation
    • For each person (index case or related) included in this study:
    • Bordeaux, France
    • +4 more
    Aug 28, 2023

    Carotid Plaque Burden in Philadelphia Negative

    Recruiting
    • Myeloproliferative Neoplasm
      • Sohag, Egypt
        Faculty of Medicine
      Aug 14, 2023

      Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

      Recruiting
      • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
      • Montpellier, France
      • +7 more
      Dec 19, 2022

      Myeloid Leukemia, MDS Trial (IFN-?)

      Not yet recruiting
      • Myeloid Leukemia
      • Myelodysplastic Syndromes
      • (no location specified)
      Nov 15, 2023

      Breast Cancer Trial in New York (core needle biopsy, blood draw)

      Recruiting
      • Breast Cancer
      • core needle biopsy
      • blood draw
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Nov 9, 2023

      NSCLC Trial in Guangzhou (PLB1001)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Aug 15, 2023

      Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

      Not yet recruiting
      • Leber Hereditary Optic Neuropathy (LHON)
      • NFS-02 Injection
      • (no location specified)
      Apr 6, 2023

      Trial

      Not yet recruiting
      • Leber Hereditary Optic Neuropathy (LHON)
      • NR082 Injection
      • Injection needle
      • (no location specified)
      Jan 30, 2023

      Advanced Solid Tumors Trial in Worldwide (MK-1084, Pembrolizumab)

      Recruiting
      • Advanced Solid Tumors
      • Grand Rapids, Michigan
      • +39 more
      Jan 25, 2023

      NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)

      Active, not recruiting
      • Non-small Cell Lung Cancer Metastatic
      • Non-small Cell Lung Cancer Stage III
      • La Jolla, California
      • +5 more
      Aug 12, 2022

      Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA)

      Completed
      • Cystic Fibrosis
      • Tucson, Arizona
      • +83 more
      Jan 20, 2023

      The Prevelence of IVS 1-6 [HBB:c.92 +6 T-C] Gene Mutation in

      Not yet recruiting
      • Beta-Thalassemia
      • ARMS
      • (no location specified)
      May 10, 2022

      A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

      Not yet recruiting
      • C-KIT Mutation
        • (no location specified)
        Nov 2, 2023

        Aumolertinib, Anlotinib, TP53 Trial (Aumolertinib,Anlotinib)

        Not yet recruiting
        • Aumolertinib
        • +4 more
        • (no location specified)
        Mar 8, 2023

        Triple Negative Breast Tumors Trial in Worldwide (alpelisib, , nab-paclitaxel)

        Active, not recruiting
        • Triple Negative Breast Neoplasms
        • Los Alamitos, California
        • +154 more
        Jan 12, 2023

        Cystic Fibrosis, Pulmonary Trial in Shanghai (Sweat Test)

        Recruiting
        • Cystic Fibrosis, Pulmonary
        • Sweat Test
        • Shanghai, Shanghai, China
          Shanghai pulmonary hospital
        Oct 31, 2022